Iron dextran
Ferrlecit, Infed, Velphoro, Venofer (iron dextran) is an unknown pharmaceutical. Iron dextran was first approved as Infed on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Ferrlecit, Infed, Velphoro, Venofer (generic drugs available since 2011-03-31, discontinued: Dexferrum, Iron dextran, Proferdex)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Ferric Oxyhydroxide, Velphoro, Vifor Fresenius | |||
| 10624855 | 2034-11-26 | DP | |
| 11234938 | 2034-11-26 | DP | |
| 11446252 | 2034-11-26 | DP | |
| 9561251 | 2030-01-23 | DP | U-1468 |
| 10682376 | 2028-11-13 | DP | |
| 10695367 | 2028-11-13 | DP | |
| 10925896 | 2028-11-13 | DP | |
| 10925897 | 2028-11-13 | DP | |
| 10933090 | 2028-11-13 | DP | |
| 11013761 | 2028-11-13 | DP | |
| 11013762 | 2028-11-13 | DP | |
ATC Codes
No data
HCPCS
Code | Description |
|---|---|
| J1750 | Injection, iron dextran, 50 mg |
Clinical
Clinical Trials
2 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Renal insufficiency | D051437 | HP_0000083 | N19 | — | — | — | — | 1 | 1 |
| Kidney transplantation | D016030 | — | — | — | — | 1 | 1 | ||
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | IRON DEXTRAN |
| INN | — |
| Description | Iron supplements, also known as iron salts and iron pills, are a number of iron formulations used to treat and prevent iron deficiency including iron deficiency anemia. For prevention they are only recommended in those with poor absorption, heavy menstrual periods, pregnancy, hemodialysis, or a diet low in iron. Prevention may also be used in low birth weight babies. They are taken by mouth, injection into a vein, or injection into a muscle. While benefits may be seen in days, up to two months may be required until iron levels return to normal.
|
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 10028-22-5 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1201544 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 3,655 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
28 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more